The MIND Study: Modifying the INcidence of Delirium

NCT00096863 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

OTHER

Sponsor class

Conditions

Delirium
Cognition Disorders

Interventions

DRUG: Ziprasidone
DRUG: Haloperidol
OTHER: Placebo

Sponsor

Vanderbilt University